Alexion Pharmaceuticals, Inc.

Wealthfront Advisers LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/16/2021

Shares

6,269

Value ($000)

1,152

Weight

0.0%

2020 Q2 - 2021 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/16/2021	1,152	0.0%	6,269	6/30/2021
2021 Q1	5/14/2021	714	0.0%	4,671	3/31/2021
2020 Q4	2/16/2021	587	0.0%	3,754	12/31/2020
2020 Q3	11/16/2020	387	0.0%	3,384	9/30/2020
2020 Q2	8/14/2020	355	0.0%	3,160	6/30/2020